← Back to Search

Hydrogel Nanoparticle Wound Dressing

Altrazeal Flexible Hydrogel Nanoparticle Wound Dressing for Burns (ROM Trial)

N/A
Waitlist Available
Research Sponsored by ULURU Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

The objective of this study is to evaluate the difference in joint range of motion of a new flexible hydrogel nanoparticle wound dressing compared to typical sodium carboxymethylcellulose dressing Aquacel AG for treatment of partial thickness burns.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Altrazeal Flexible Hydrogel Nanoparticle Wound DressingExperimental Treatment1 Intervention
Nanoflex Powder Dressing applied to joint
Group II: Aquacel AG, typical carboxymethylcellulose dressingActive Control1 Intervention
Sodium CMC dressing control applied to joint

Find a Location

Who is running the clinical trial?

ULURU Inc.Lead Sponsor
4 Previous Clinical Trials
600 Total Patients Enrolled
~0 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top